奥美沙坦
药理学
前药
化学
抗高血压药
医学
内科学
血压
作者
Bommena Hanumantha Rao,Inti V. Subramanyeswara Rao,Vysyaraju Ravi Kanth,Korrapati Venkata Vara Prasadarao,K. Balamurali Krishna,Bethanabatla Syama Sundar
出处
期刊:Indo American Journal of Pharmaceutical Research
日期:2015-01-01
卷期号:5 (9): 2744-2751
摘要
Article history Olmesartan medoxomil is a prodrug within the class of angiotensin receptor antagonists, approved by the FDA for the treatment of hypertension. Present work describes the origin, synthesis and characterization of four process related novel impurities of olmesartan medoxomil viz. olmesartan chloro medoxomil, olmesartan medoxomil dimer, olmesartan diol and quaternary salt impurities.
科研通智能强力驱动
Strongly Powered by AbleSci AI